A new $16,000 postpartum depression drug is here. How will insurers handle it?

FHS
March 12, 2024
10:49 am

A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness.

RFK Jr. Vows to Legalize Psychedelics and Marijuana, Allocating Revenue for Healing Centers Supporting Addiction Recovery | Psychedelic Spotlight

Robert F. Kennedy Jr., the 2024 Democratic presidential legacy candidate with what may be the most famous last name in U.S. politics, says that he

June 29, 2023

Flagship poaches another pharma R&D leader as GSK’s Lepore heads to ProFound

John Lepore, the former right-hand man for Hal Barron and Tony Wood at GSK, is departing the UK pharma giant to lead a Flagship Pioneering

October 3, 2023

New approach for cervical cancer vaccines based on microsphere-encapsulated peptides

Infection with HPV16, a high-risk human papillomavirus (HPV), can cause cervical cancer in humans. These infections carry a high risk of morbidity and mortality globally

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.